Segall Bryant & Hamill’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,633
Closed -$897K 577
2025
Q4
$897K Sell
22,633
-111
-0.5% -$4.18K 0.01% 514
2025
Q3
$872K Sell
22,744
-244
-1% -$9.05K 0.01% 514
2025
Q2
$854K Sell
22,988
-3,233
-12% -$115K 0.01% 515
2025
Q1
$911K Sell
26,221
-241
-0.9% -$8.06K 0.01% 510
2024
Q4
$857K Buy
26,462
+9,331
+54% +$323K 0.01% 523
2024
Q3
$622K Buy
17,131
+357
+2% +$12.2K 0.01% 536
2024
Q2
$514K Buy
+16,774
New +$511K 0.01% 400

Other funds holding ACT

Segall Bryant & Hamill's ACT Position: Q1 2026 in Review

Segall Bryant & Hamill sold out of Enact Holdings (ACT) in Q1 2026, closing a stake of 22,633 shares — an estimated $897K sold.

Segall Bryant & Hamill first reported a position in ACT in Q2 2024 and held it in 7 quarters. The position peaked at $911K in Q1 2025. 253 funds tracked by Wall St. Rank hold ACT as of Q1 2026.

  • Segall Bryant & Hamill reported no remaining Enact Holdings position as of Q1 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 22,633 Enact Holdings shares in Q1 2026, an estimated $897K.
  • Segall Bryant & Hamill first reported a position in Enact Holdings in Q2 2024 and held it in 7 quarters.
  • Segall Bryant & Hamill's Enact Holdings position peaked at $911K in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Enact Holdings as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.